157 related articles for article (PubMed ID: 1313157)
41. Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly).
Bhargava HN; Ramarao P
Life Sci; 1989; 45(26):2521-8. PubMed ID: 2559273
[TBL] [Abstract][Full Text] [Related]
42. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
Fukagawa Y; Katz JL; Suzuki T
Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
[TBL] [Abstract][Full Text] [Related]
43. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
[TBL] [Abstract][Full Text] [Related]
44. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
45. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
Bhargava HN; Thorat SN
Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
[TBL] [Abstract][Full Text] [Related]
46. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
Xia Q; Sheng JZ; Tai KK; Wong TM
J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
[TBL] [Abstract][Full Text] [Related]
47. Effects of a kappa-receptor agonist, U-50,488H, on the release of endogenous brain dopamine.
Clow DW; Jhamandas K
Can J Physiol Pharmacol; 1988 Feb; 66(2):128-33. PubMed ID: 2836044
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions.
Ohno M; Yamamoto T; Ueki S
Psychopharmacology (Berl); 1989; 97(2):219-21. PubMed ID: 2543013
[TBL] [Abstract][Full Text] [Related]
49. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
51. Pituitary-adrenocortical response to acute and chronic administration of U-50,488H in the rat.
Milanés MV; Gonzalvez ML; Fuente T; Vargas ML
Neuropeptides; 1991 Oct; 20(2):95-102. PubMed ID: 1665898
[TBL] [Abstract][Full Text] [Related]
52. Effects of morphine tolerance-dependence and abstinence on kappa-opiate receptors of rat brain and spinal cord.
Bhargava HN; Gulati A; Rahmani NH
Biochem Pharmacol; 1991 Aug; 42(6):1302-6. PubMed ID: 1653568
[No Abstract] [Full Text] [Related]
53. Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats.
Gulati A; Bhargava HN
Eur J Pharmacol; 1990 Jul; 182(2):253-9. PubMed ID: 2144490
[TBL] [Abstract][Full Text] [Related]
54. Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat.
Gudehithlu KP; Reddy PL; Bhargava HN
Brain Res; 1994 Mar; 639(2):269-74. PubMed ID: 7911390
[TBL] [Abstract][Full Text] [Related]
55. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
Bhargava HN; Das S
Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
[TBL] [Abstract][Full Text] [Related]
56. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Bhargava HN; Thorat SN
Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
[TBL] [Abstract][Full Text] [Related]
57. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain.
Periyasamy S; Hoss W
Life Sci; 1990; 47(3):219-25. PubMed ID: 1975082
[TBL] [Abstract][Full Text] [Related]
58. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
59. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats.
Gudehithlu KP; Tejwani GA; Bhargava HN
Brain Res; 1991 Jul; 553(2):284-90. PubMed ID: 1933285
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous modulation of TRH and opioid receptor binding in rat spinal cord after chronic naloxone administration.
Krumins SA
Neuropeptides; 1988 Jan; 11(1):47-52. PubMed ID: 2835703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
